Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Very high cell density perfusion of CHO cells anchored in a non-woven matrix-based bioreactor
KTH, School of Biotechnology (BIO), Industrial Biotechnology. KTH, School of Biotechnology (BIO), Centres, Centre for Bioprocess Technology, CBioPT.ORCID iD: 0000-0002-0841-8845
KTH, School of Biotechnology (BIO), Industrial Biotechnology. (Bioprocess Design, Cell Technology Group CETEG)ORCID iD: 0000-0002-5370-4621
2015 (English)In: Journal of Biotechnology, ISSN 0168-1656, E-ISSN 1873-4863, Vol. 213, 28-41 p.Article in journal (Refereed) Published
Abstract [en]

Recombinant Chinese Hamster Ovary (CHO) cells producing IgG monoclonal antibody were cultivated in a novel perfusion culture system CellTank, integrating the bioreactor and the cell retention function. In this system, the cells were harbored in a non-woven polyester matrix perfused by the culture medium and immersed in a reservoir. Although adapted to suspension, the CHO cells stayed entrapped in the matrix. The cell-free medium was efficiently circulated from the reservoir into- and through the matrix by a centrifugal pump placed at the bottom of the bioreactor resulting in highly homogenous concentrations of the nutrients and metabolites in the whole system as confirmed by measurements from different sampling locations. A real-time biomass sensor using the dielectric properties of living cells was used to measure the cell density. The performances of the CellTank were studied in three perfusion runs. A very high cell density measured as 200 pF/cm (where 1 pF/cm is equivalent to 1 x 106 viable cells/mL) was achieved at a perfusion rate of 10 reactor volumes per day (RV/day) in the first run. In the second run, the effect of cell growth arrest by hypothermia at temperatures lowered gradually from 37 C to 29 C was studied during 13 days at cell densities above 100 pF/cm. Finally a production run was performed at high cell densities, where a temperature shift to 31 C was applied at cell density 100 pF/cm during a production period of 14 days in minimized feeding conditions. The IgG concentrations were comparable in the matrix and in the harvest line in all the runs, indicating no retention of the product of interest. The cell specific productivity was comparable or higher than in Erlenmeyer flask batch culture. During the production run, the final harvested IgG production was 35 times higher in the CellTank compared to a repeated batch culture in the same vessel volume during the same time period.

Place, publisher, year, edition, pages
[Zhang, Ye; Chotteau, Veronique] KTH, Royal Inst Technol, Cell Technol Grp CETEG, Sch Biotechnol,Dept Ind Biotechnol Bioproc Design, SE-10691 Stockholm, Sweden. [Stobbe, Per] PerfuseCell, DK-2840 Holte, Denmark. [Silvander, Christian Orrego] Belach Biotekn, SE-14250 Skogas, Sweden., 2015. Vol. 213, 28-41 p.
Keyword [en]
Disposable bioreactor, On-line biomass sensor, IgG production, Dielectric spectroscopy, Hypothermia
National Category
Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)
Identifiers
URN: urn:nbn:se:kth:diva-176326DOI: 10.1016/j.jbiotec.2015.07.006ISI: 000362286400005PubMedID: 26211737Scopus ID: 2-s2.0-84942837005OAI: oai:DiVA.org:kth-176326DiVA: diva2:871898
Note

QC 20151117

Available from: 2015-11-17 Created: 2015-11-03 Last updated: 2017-05-23Bibliographically approved
In thesis
1. High cell density perfusion process development for antibody producing Chinese Hamster Ovary cells
Open this publication in new window or tab >>High cell density perfusion process development for antibody producing Chinese Hamster Ovary cells
2017 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Perfusion operation mode is currently under fast expansion in mammalian cell based manufacturing of biopharmaceuticals, not only for labile drug protein but also for stable proteins such as monoclonal antibodies (mAbs). Perfusion mode can advantageously offer a stable cell environment, long-term production with high productivity and consistent product quality. Intensified high cell density culture (HCDC) is certainly one of the most attractive features of a perfusion process due to the high volumetric productivity in a small footprint that it can provide. Advancements in single-use technology have alleviated the intrinsic complexity of perfusion processes while the maturing in cell retention devices has improved process robustness. The knowledge for perfusion process has been gradually built and the “continuous” concept is getting more and more acceptance in the field.

This thesis presents the development of robust perfusion process at very high cell densities in various culture systems. Four HCDC perfusion systems were developed with industrial collaborators with three different mAb producing Chinese Hamster Ovary (CHO) cell lines: 1-2) WAVE Bioreactor™ Cellbag prototype equipped with cell separation by hollow fiber filter utilizing Alternating Tangential Flow (ATF) and Tangential Flow Filtration (TFF) techniques; 3) Fiber matrix based CellTank™ prototype; 4) Glass stirred tank bioreactor equipped with ATF. In all the systems, extremely high viable cell densities above 130 million viable cells per milliliter (MVC/mL) up to 214 MVC/mL were achieved. Steady states were maintained and studied at 20-30 MVC/mL and 100-130 MVC/mL for process development. Perfusion rate selection based on cell specific perfusion rate (CSPR) was systematically investigated and exometabolome study was performed to explore the metabolic footprint of HCDC perfusion process.

Place, publisher, year, edition, pages
Stockholm: KTH Royal Institute of Technology, 2017. 79 p.
Series
TRITA-BIO-Report, ISSN 1654-2312 ; 2017:14
Keyword
WAVE Bioreactor, Cellbag, ATF, TFF, hollow fiber, CSPR, CellTank, SUB, single-use-bioreactor, disposable, perfusion rate
National Category
Bioprocess Technology
Research subject
Biotechnology
Identifiers
urn:nbn:se:kth:diva-207600 (URN)978-91-7729-450-4 (ISBN)
Public defence
2017-06-14, FB54, Albanova, plan_5, Stockholm, 14:00 (English)
Opponent
Supervisors
Note

QC 20170523

Available from: 2017-05-23 Created: 2017-05-22 Last updated: 2017-05-29Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedScopus

Authority records BETA

Zhang, YeChotteau, Veronique

Search in DiVA

By author/editor
Zhang, YeChotteau, Veronique
By organisation
Industrial BiotechnologyCentre for Bioprocess Technology, CBioPT
In the same journal
Journal of Biotechnology
Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 192 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf